Targets and consequences of protein SUMOylation in neurons

Agbor, 2008, SUMO, hypoxia and the regulation of metabolism, Biochem. Soc. Trans., 36, 445, 10.1042/BST0360445 Ahima, 2000, Leptin, Annu. Rev. Physiol., 62, 413, 10.1146/annurev.physiol.62.1.413 Ahn, 2009, Ubc9 gene polymorphisms and late-onset Alzheimer's disease in the Korean population: a genetic association study, Neurosci. Lett., 465, 272, 10.1016/j.neulet.2009.09.017 Anderson, 2009, Protein SUMOylation in neuropathological conditions, Drug News Perspect., 22, 255, 10.1358/dnp.2009.22.5.1378636 Appella, 2001, Post-translational modifications and activation of p53 by genotoxic stresses, Eur. J. Biochem., 268, 2764, 10.1046/j.1432-1327.2001.02225.x Bauer, 1992, Phosducin is a protein kinase A-regulated G-protein regulator, Nature, 358, 73, 10.1038/358073a0 Bence, 2006, Neuronal PTP1B regulates body weight, adiposity and leptin action, Nat. Med., 12, 917, 10.1038/nm1435 Benson, 2007, SUMO modification regulates inactivation of the voltage-gated potassium channel Kv1.5, Proc. Natl. Acad. Sci. USA, 104, 1805, 10.1073/pnas.0606702104 Berciano, 2007, Cajal body number and nucleolar size correlate with the cell body mass in human sensory ganglia neurons, J. Struct. Biol., 158, 410, 10.1016/j.jsb.2006.12.008 Berman, 1998, Mammalian RGS proteins: barbarians at the gate, J. Biol. Chem., 273, 1269, 10.1074/jbc.273.3.1269 Besnault-Mascard, 2005, Caspase-8 sumoylation is associated with nuclear localization, Oncogene, 24, 3268, 10.1038/sj.onc.1208448 Bhat, 2004, Glycogen synthase kinase 3: a drug target for CNS therapies, J. Neurochem., 89, 1313, 10.1111/j.1471-4159.2004.02422.x Blackshaw, 2004, Genomic analysis of mouse retinal development, PLoS Biol., 2, E247, 10.1371/journal.pbio.0020247 Bohren, 2004, A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus, J. Biol. Chem., 279, 27233, 10.1074/jbc.M402273200 Bossis, 2006, Regulation of SUMOylation by reversible oxidation of SUMO conjugating enzymes, Mol. Cell, 21, 349, 10.1016/j.molcel.2005.12.019 Braschi, 2009, MAPL is a new mitochondrial SUMO E3 ligase that regulates mitochondrial fission, EMBO Rep., 10, 748, 10.1038/embor.2009.86 Bryant, 2002, Regulated transport of the glucose transporter GLUT4, Nat. Rev. Mol. Cell Biol., 3, 267, 10.1038/nrm782 Cardone, 2005, Circadian clock control by SUMOylation of BMAL1, Science, 309, 1390, 10.1126/science.1110689 Carter, 2007, C-terminal modifications regulate MDM2 dissociation and nuclear export of p53, Nat. Cell Biol., 9, 428, 10.1038/ncb1562 Carvalho, 1999, The spinal muscular atrophy disease gene product, SMN: A link between snRNP biogenesis and the Cajal (coiled) body, J. Cell Biol., 147, 715, 10.1083/jcb.147.4.715 Chan, 2006, Mitochondrial fusion and fission in mammals, Annu. Rev. Cell Dev. Biol., 22, 79, 10.1146/annurev.cellbio.22.010305.104638 Chan, 2002, Genetic modulation of polyglutamine toxicity by protein conjugation pathways in Drosophila, Hum. Mol. Genet., 11, 2895, 10.1093/hmg/11.23.2895 Chao, 2008, SUMOylation of the MAGUK protein CASK regulates dendritic spinogenesis, J. Cell Biol., 182, 141, 10.1083/jcb.200712094 Chen, 1998, Transforming growth factor beta type I receptor kinase mutant associated with metastatic breast cancer, Cancer Res., 58, 4805 Chen, 2001, Novel inactivating mutations of transforming growth factor-beta type I receptor gene in head-and-neck cancer metastases, Int. J. Cancer, 93, 653, 10.1002/ijc.1381 Cimarosti, 2008, Investigating the mechanisms underlying neuronal death in ischemia using in vitro oxygen-glucose deprivation: potential involvement of protein SUMOylation, Neuroscientist, 14, 626, 10.1177/1073858408322677 Cimarosti, 2008, Increased protein SUMOylation following focal cerebral ischemia, Neuropharmacology, 54, 280, 10.1016/j.neuropharm.2007.09.010 Dadke, 2007, Regulation of protein tyrosine phosphatase 1B by sumoylation, Nat. Cell Biol., 9, 80, 10.1038/ncb1522 Dorval, 2006, Small ubiquitin-like modifier (SUMO) modification of natively unfolded proteins tau and alpha-synuclein, J. Biol. Chem., 281, 9919, 10.1074/jbc.M510127200 Dorval, 2007, SUMO on the road to neurodegeneration, Biochim. Biophys. Acta, 1773, 694, 10.1016/j.bbamcr.2007.03.017 Dorval, 2007, Modulation of Abeta generation by small ubiquitin-like modifiers does not require conjugation to target proteins, Biochem. J., 404, 309, 10.1042/BJ20061451 Dube, 2005, Involvement of the small protein tyrosine phosphatases TC-PTP and PTP1B in signal transduction and diseases: from diabetes, obesity to cell cycle, and cancer, Biochim. Biophys. Acta, 1754, 108, 10.1016/j.bbapap.2005.07.030 Eizenberg, 1996, p53 plays a regulatory role in differentiation and apoptosis of central nervous system-associated cells, Mol. Cell. Biol., 16, 5178, 10.1128/MCB.16.9.5178 Eldar-Finkelman, 2002, Glycogen synthase kinase 3: an emerging therapeutic target, Trends Mol. Med., 8, 126, 10.1016/S1471-4914(01)02266-3 Eun Jeoung, 2008, Regulation of glycogen synthase kinase 3beta functions by modification of the small ubiquitin-like modifier, Open Biochem. J., 2, 67, 10.2174/1874091X00802010067 Feliciangeli, 2007, Does sumoylation control K2P1/TWIK1 background K+ channels?, Cell, 130, 563, 10.1016/j.cell.2007.06.012 Feliciangeli, 2010, Potassium channel silencing by constitutive endocytosis and intracellular sequestration, J. Biol. Chem., 285, 4798, 10.1074/jbc.M109.078535 Feligioni, 2009, Protein SUMOylation modulates calcium influx and glutamate release from presynaptic terminals, Eur. J. Neurosci., 29, 1348, 10.1111/j.1460-9568.2009.06692.x Figueroa-Romero, 2009, SUMOylation of the mitochondrial fission protein Drp1 occurs at multiple nonconsensus sites within the B domain and is linked to its activity cycle, FASEB J., 23, 3917, 10.1096/fj.09-136630 Flanders, 1998, Transforming growth factor-betas in neurodegenerative disease, Prog. Neurobiol., 54, 71, 10.1016/S0301-0082(97)00066-X Flavell, 2006, Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number, Science, 311, 1008, 10.1126/science.1122511 Gatchel, 2005, Diseases of unstable repeat expansion: mechanisms and common principles, Nat. Rev. Genet., 6, 743, 10.1038/nrg1691 Geiss-Friedlander, 2007, Concepts in sumoylation: a decade on, Nat. Rev. Mol. Cell Biol., 8, 947, 10.1038/nrm2293 Geoffroy, 2009, An additional role for SUMO in ubiquitin-mediated proteolysis, Nat. Rev. Mol. Cell Biol., 10, 564, 10.1038/nrm2707 Gil, 2008, Mechanisms of neurodegeneration in Huntington's disease, Eur. J. Neurosci., 27, 2803, 10.1111/j.1460-9568.2008.06310.x Giorgino, 2000, The sentrin-conjugating enzyme mUbc9 interacts with GLUT4 and GLUT1 glucose transporters and regulates transporter levels in skeletal muscle cells, Proc. Natl. Acad. Sci. USA, 97, 1125, 10.1073/pnas.97.3.1125 Giuditta, 2002, Axonal and presynaptic protein synthesis: new insights into the biology of the neuron, Trends Neurosci., 25, 400, 10.1016/S0166-2236(02)02188-4 Gocke, 2005, Systematic identification and analysis of mammalian small ubiquitin-like modifier substrates, J. Biol. Chem., 280, 5004, 10.1074/jbc.M411718200 Gong, 1999, Molecular cloning and characterization of human AOS1 and UBA2, components of the sentrin-activating enzyme complex, FEBS Lett., 448, 185, 10.1016/S0014-5793(99)00367-1 Gostissa, 1999, Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1, EMBO J., 18, 6462, 10.1093/emboj/18.22.6462 Gowran, 2009, Delta(9)-tetrahydrocannabinol regulates the p53 post-translational modifiers Murine double minute 2 and the small ubiquitin modifier protein in the rat brain, FEBS Lett., 583, 3412, 10.1016/j.febslet.2009.09.056 Hankins, 2008, Melanopsin: an exciting photopigment, Trends Neurosci., 31, 27, 10.1016/j.tins.2007.11.002 Hardeland, 2002, Modification of the human thymine-DNA glycosylase by ubiquitin-like proteins facilitates enzymatic turnover, EMBO J., 21, 1456, 10.1093/emboj/21.6.1456 Harder, 2004, Sumo1 conjugates mitochondrial substrates and participates in mitochondrial fission, Curr. Biol., 14, 340, 10.1016/j.cub.2004.02.004 Hay, 2005, SUMO: a history of modification, Mol. Cell, 18, 1, 10.1016/j.molcel.2005.03.012 Hayashi, 2002, Ubc9 is essential for viability of higher eukaryotic cells, Exp. Cell Res., 280, 212, 10.1006/excr.2002.5634 Hayashi, 2006, Relationship between SUMO-1 modification of caspase-7 and its nuclear localization in human neuronal cells, Neurosci. Lett., 397, 5, 10.1016/j.neulet.2005.11.057 Heun, 2007, SUMOrganization of the nucleus, Curr. Opin. Cell Biol., 19, 350, 10.1016/j.ceb.2007.04.014 Hietakangas, 2006, PDSM, a motif for phosphorylation-dependent SUMO modification, Proc. Natl. Acad. Sci. USA, 103, 45, 10.1073/pnas.0503698102 Hilgarth, 2004, Regulation and function of SUMO modification, J. Biol. Chem., 279, 53899, 10.1074/jbc.R400021200 Hirokawa, 2005, Molecular motors and mechanisms of directional transport in neurons, Nat. Rev. Neurosci., 6, 201, 10.1038/nrn1624 Hofmann, 2000, Covalent modification of the transactivator protein IE2-p86 of human cytomegalovirus by conjugation to the ubiquitin-homologous proteins SUMO-1 and hSMT3b, J. Virol., 74, 2510, 10.1128/JVI.74.6.2510-2524.2000 Ishihara, 2009, Mitochondrial fission factor Drp1 is essential for embryonic development and synapse formation in mice, Nat. Cell Biol., 11, 958, 10.1038/ncb1907 Ja Lee, 2009, SUMOylation participates in induction of ischemic tolerance, J. Neurochem., 109, 257, 10.1111/j.1471-4159.2009.05957.x Janer, 2010, SUMOylation attenuates the aggregation propensity and cellular toxicity of the polyglutamine expanded ataxin-7, Hum. Mol. Genet., 19, 181, 10.1093/hmg/ddp478 Jaskolski, 2005, Subcellular localization and trafficking of kainate receptors, Trends Pharmacol. Sci., 26, 20, 10.1016/j.tips.2004.11.008 Johnson, 2004, Protein modification by SUMO, Annu. Rev. Biochem., 73, 355, 10.1146/annurev.biochem.73.011303.074118 Kadare, 2003, PIAS1-mediated sumoylation of focal adhesion kinase activates its autophosphorylation, J. Biol. Chem., 278, 47434, 10.1074/jbc.M308562200 Kang, 2008, The type I TGF-beta receptor is covalently modified and regulated by sumoylation, Nat. Cell Biol., 10, 654, 10.1038/ncb1728 Katsuno, 2006, Pathogenesis, animal models and therapeutics in spinal and bulbar muscular atrophy (SBMA), Exp. Neurol., 200, 8, 10.1016/j.expneurol.2006.01.021 Kim, 2009, Emerging roles of desumoylating enzymes, Biochim. Biophys. Acta, 1792, 155, 10.1016/j.bbadis.2008.12.008 Klenk, 2006, SUMO-1 controls the protein stability and the biological function of phosducin, J. Biol. Chem., 281, 8357, 10.1074/jbc.M513703200 Kozlovsky, 2002, GSK-3 and the neurodevelopmental hypothesis of schizophrenia, Eur. Neuropsychopharmacol., 12, 13, 10.1016/S0924-977X(01)00131-6 Lapenta, 1997, SMT3A, a human homologue of the S. cerevisiae SMT3 gene, maps to chromosome 21qter and defines a novel gene family, Genomics, 40, 362, 10.1006/geno.1996.4556 Lavin, 2006, The complexity of p53 stabilization and activation, Cell Death Differ., 13, 941, 10.1038/sj.cdd.4401925 Lee, 2009, SUMO modification of DNA topoisomerase II: trying to get a CENse of it all, DNA Repair (Amst.), 8, 557, 10.1016/j.dnarep.2009.01.004 Lee, 2008, Dual modification of BMAL1 by SUMO2/3 and ubiquitin promotes circadian activation of the CLOCK/BMAL1 complex, Mol. Cell. Biol., 28, 6056, 10.1128/MCB.00583-08 Levine, 1997, p53, the cellular gatekeeper for growth and division, Cell, 88, 323, 10.1016/S0092-8674(00)81871-1 Li, 1998, Mammalian DNA topoisomerase IIIalpha is essential in early embryogenesis, Proc. Natl. Acad. Sci. USA, 95, 1010, 10.1073/pnas.95.3.1010 Li, 2003, Positive and negative regulation of APP amyloidogenesis by sumoylation, Proc. Natl. Acad. Sci. USA, 100, 259, 10.1073/pnas.0235361100 Li, 2004, The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses, Cell, 119, 873, 10.1016/j.cell.2004.11.003 Liu, 2007, The SUMO conjugating enzyme Ubc9 is a regulator of GLUT4 turnover and targeting to the insulin-responsive storage compartment in 3T3-L1 adipocytes, Diabetes, 56, 1977, 10.2337/db06-1100 Lu, 2009, The activity-dependent stimuli increase SUMO modification in SHSY5Y cells, Biochem. Biophys. Res. Commun., 390, 872, 10.1016/j.bbrc.2009.10.065 Mahajan, 1997, A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2, Cell, 88, 97, 10.1016/S0092-8674(00)81862-0 Mao, 2000, SUMO-1 conjugation to human DNA topoisomerase II isozymes, J. Biol. Chem., 275, 26066, 10.1074/jbc.M001831200 Mao, 2000, SUMO-1 conjugation to topoisomerase I: A possible repair response to topoisomerase-mediated DNA damage, Proc. Natl. Acad. Sci. USA, 97, 4046, 10.1073/pnas.080536597 Mao, 2004, RGS17/RGSZ2, a novel regulator of Gi/o, Gz, and Gq signaling, J. Biol. Chem., 279, 26314, 10.1074/jbc.M401800200 Martin, 2004, Local protein synthesis during axon guidance and synaptic plasticity, Curr. Opin. Neurobiol., 14, 305, 10.1016/j.conb.2004.05.009 Martin, 2007, SUMOylation regulates kainate-receptor-mediated synaptic transmission, Nature, 447, 321, 10.1038/nature05736 Martin, 2007, Emerging extranuclear roles of protein SUMOylation in neuronal function and dysfunction, Nat. Rev. Neurosci., 8, 948, 10.1038/nrn2276 Matunis, 1996, A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex, J. Cell Biol., 135, 1457, 10.1083/jcb.135.6.1457 McBride, 2006, Mitochondria: more than just a powerhouse, Curr. Biol., 16, R551, 10.1016/j.cub.2006.06.054 McFadden, 2005, Neuronal intranuclear inclusion disease without polyglutamine inclusions in a child, J. Neuropathol. Exp. Neurol., 64, 545, 10.1093/jnen/64.6.545 Melchior, 2002, SUMO-1 and p53, Cell Cycle, 1, 245, 10.4161/cc.1.4.131 Meulmeester, 2008, Cell biology: SUMO, Nature, 452, 709, 10.1038/452709a Minty, 2000, Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif, J. Biol. Chem., 275, 36316, 10.1074/jbc.M004293200 Mishra, 2004, Dynamin interacts with members of the sumoylation machinery, J. Biol. Chem., 279, 31445, 10.1074/jbc.M402911200 Mitra, 2005, Focal adhesion kinase: in command and control of cell motility, Nat. Rev. Mol. Cell Biol., 6, 56, 10.1038/nrm1549 Mukherjee, 2009, Small ubiquitin-like modifier (SUMO) modification of the androgen receptor attenuates polyglutamine-mediated aggregation, J. Biol. Chem., 284, 21296, 10.1074/jbc.M109.011494 Mukhopadhyay, 2007, Modification in reverse: the SUMO proteases, Trends Biochem. Sci., 32, 286, 10.1016/j.tibs.2007.05.002 Muller, 2001, SUMO, ubiquitin's mysterious cousin, Nat. Rev. Mol. Cell Biol., 2, 202, 10.1038/35056591 Nacerddine, 2005, The SUMO pathway is essential for nuclear integrity and chromosome segregation in mice, Dev. Cell, 9, 769, 10.1016/j.devcel.2005.10.007 Navascues, 2008, SUMO-1 transiently localizes to Cajal bodies in mammalian neurons, J. Struct. Biol., 163, 137, 10.1016/j.jsb.2008.04.013 Neef, 2006, Dementia with Lewy bodies: an emerging disease, Am. Fam. Physician, 73, 1223 Neuspiel, 2008, Cargo-selected transport from the mitochondria to peroxisomes is mediated by vesicular carriers, Curr. Biol., 18, 102, 10.1016/j.cub.2007.12.038 Nimchinsky, 2002, Structure and function of dendritic spines, Annu. Rev. Physiol., 64, 313, 10.1146/annurev.physiol.64.081501.160008 Nishida, 2002, PIAS1 and PIASxalpha function as SUMO-E3 ligases toward androgen receptor and repress androgen receptor-dependent transcription, J. Biol. Chem., 277, 41311, 10.1074/jbc.M206741200 Onishi, 2009, Pias3-dependent SUMOylation directs rod photoreceptor development, Neuron, 61, 234, 10.1016/j.neuron.2008.12.006 Orias, 1997, Cloning and localization of a double-pore K channel, KCNK1: exclusive expression in distal nephron segments, Am. J. Physiol., 273, F663 Owerbach, 2005, A proline-90 residue unique to SUMO-4 prevents maturation and sumoylation, Biochem. Biophys. Res. Commun., 337, 517, 10.1016/j.bbrc.2005.09.090 Palancade, 2008, Sumoylating and desumoylating enzymes at nuclear pores: underpinning their unexpected duties?, Trends Cell Biol., 18, 174, 10.1016/j.tcb.2008.02.001 Peineau, 2007, LTP inhibits LTD in the hippocampus via regulation of GSK3beta, Neuron, 53, 703, 10.1016/j.neuron.2007.01.029 Pierce, 2002, Seven-transmembrane receptors, Nat. Rev. Mol. Cell Biol., 3, 639, 10.1038/nrm908 Pinheiro, 2006, Kainate receptors, Cell Tissue Res., 326, 457, 10.1007/s00441-006-0265-6 Plant, 2005, K2P channels and their protein partners, Curr. Opin. Neurobiol., 15, 326, 10.1016/j.conb.2005.05.008 Poukka, 2000, Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1), Proc. Natl. Acad. Sci. USA, 97, 14145, 10.1073/pnas.97.26.14145 Pountney, 2003, SUMO-1 marks the nuclear inclusions in familial neuronal intranuclear inclusion disease, Exp. Neurol., 184, 436, 10.1016/j.expneurol.2003.07.004 Pountney, 2005, SUMO-1 marks subdomains within glial cytoplasmic inclusions of multiple system atrophy, Neurosci. Lett., 381, 74, 10.1016/j.neulet.2005.02.013 Pountney, 2008, NSF, Unc-18-1, dynamin-1 and HSP90 are inclusion body components in neuronal intranuclear inclusion disease identified by anti-SUMO-1-immunocapture, Acta Neuropathol., 116, 603, 10.1007/s00401-008-0437-4 Pratt, 1997, TGF-beta in the central nervous system: potential roles in ischemic injury and neurodegenerative diseases, Cytokine Growth Factor Rev., 8, 267, 10.1016/S1359-6101(97)00018-X Rajan, 2005, Sumoylation silences the plasma membrane leak K+channel K2P1, Cell, 121, 37, 10.1016/j.cell.2005.01.019 Reppert, 2002, Coordination of circadian timing in mammals, Nature, 418, 935, 10.1038/nature00965 Riley, 2005, SUMOylation of the polyglutamine repeat protein, ataxin-1, is dependent on a functional nuclear localization signal, J. Biol. Chem., 280, 21942, 10.1074/jbc.M501677200 Rodriguez, 1999, SUMO-1 modification activates the transcriptional response of p53, EMBO J., 18, 6455, 10.1093/emboj/18.22.6455 Rodriguez, 2001, SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting, J. Biol. Chem., 276, 12654, 10.1074/jbc.M009476200 Rodriguez-Munoz, 2007, Sumoylated RGS-Rz proteins act as scaffolds for Mu-opioid receptors and G-protein complexes in mouse brain, Neuropsychopharmacology, 32, 842, 10.1038/sj.npp.1301184 Rui, 2002, SUMO-1 modification of the C-terminal KVEKVD of Axin is required for JNK activation but has no effect on Wnt signaling, J. Biol. Chem., 277, 42981, 10.1074/jbc.M208099200 Ryu, 2010, Oxidative stress-enhanced SUMOylation and aggregation of ataxin-1: Implication of JNK pathway, Biochem. Biophys. Res. Commun., 393, 280, 10.1016/j.bbrc.2010.01.122 Sahar, 2010, Regulation of BMAL1 protein stability and circadian function by GSK3beta-mediated phosphorylation, PLoS ONE, 5, e8561, 10.1371/journal.pone.0008561 Saitoh, 2000, Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3, J. Biol. Chem., 275, 6252, 10.1074/jbc.275.9.6252 Sampson, 2001, The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification, J. Biol. Chem., 276, 21664, 10.1074/jbc.M100006200 Schilling, 1999, Nuclear accumulation of truncated atrophin-1 fragments in a transgenic mouse model of DRPLA, Neuron, 24, 275, 10.1016/S0896-6273(00)80839-9 Seeler, 2003, Nuclear and unclear functions of SUMO, Nat. Rev. Mol. Cell Biol., 4, 690, 10.1038/nrm1200 Shalizi, 2006, A calcium-regulated MEF2 sumoylation switch controls postsynaptic differentiation, Science, 311, 1012, 10.1126/science.1122513 Shalizi, 2007, PIASx is a MEF2 SUMO E3 ligase that promotes postsynaptic dendritic morphogenesis, J. Neurosci., 27, 10037, 10.1523/JNEUROSCI.0361-07.2007 Shi, 2003, Mechanisms of TGF-beta signaling from cell membrane to the nucleus, Cell, 113, 685, 10.1016/S0092-8674(03)00432-X Shinbo, 2006, Proper SUMO-1 conjugation is essential to DJ-1 to exert its full activities, Cell Death Differ., 13, 96, 10.1038/sj.cdd.4401704 Smirnova, 2001, Dynamin-related protein Drp1 is required for mitochondrial division in mammalian cells, Mol. Biol. Cell, 12, 2245, 10.1091/mbc.12.8.2245 Song, 2004, Identification of a SUMO-binding motif that recognizes SUMO-modified proteins, Proc. Natl. Acad. Sci. USA, 101, 14373, 10.1073/pnas.0403498101 Steffan, 2004, SUMO modification of Huntingtin and Huntington's disease pathology, Science, 304, 100, 10.1126/science.1092194 Stehmeier, 2009, Regulation of p53 family members by the ubiquitin-like SUMO system, DNA Repair (Amst.), 8, 491, 10.1016/j.dnarep.2009.01.002 Subramaniam, 2009, Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity, Science, 324, 1327, 10.1126/science.1172871 Sung, 1980, An unusual degenerative disorder of neurons associated with a novel intranuclear hyaline inclusion (neuronal intranuclear hyaline inclusion disease). A clinicopathological study of a case, J. Neuropathol. Exp. Neurol., 39, 107, 10.1097/00005072-198003000-00001 Taira, 2004, DJ-1 has a role in antioxidative stress to prevent cell death, EMBO Rep., 5, 213, 10.1038/sj.embor.7400074 Takahashi, 2001, DJ-1 positively regulates the androgen receptor by impairing the binding of PIASx alpha to the receptor, J. Biol. Chem., 276, 37556, 10.1074/jbc.M101730200 Takahashi-Fujigasaki, 2006, SUMOylation substrates in neuronal intranuclear inclusion disease, Neuropathol. Appl. Neurobiol., 32, 92, 10.1111/j.1365-2990.2005.00705.x Tan, 2007, Pathogenic mutations in Parkinson disease, Hum. Mutat., 28, 641, 10.1002/humu.20507 Tang, 2005, Pias1 interaction and sumoylation of metabotropic glutamate receptor 8, J. Biol. Chem., 280, 38153, 10.1074/jbc.M508168200 Tatham, 2001, Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9, J. Biol. Chem., 276, 35368, 10.1074/jbc.M104214200 Tedeschi, 2009, The tumor suppressor p53 transcriptionally regulates cGKI expression during neuronal maturation and is required for cGMP-dependent growth cone collapse, J. Neurosci., 29, 15155, 10.1523/JNEUROSCI.4416-09.2009 Tempe, 2008, SUMO under stress, Biochem. Soc. Trans., 36, 874, 10.1042/BST0360874 Terashima, 2002, SUMO-1 co-localized with mutant atrophin-1 with expanded polyglutamines accelerates intranuclear aggregation and cell death, NeuroReport, 13, 2359, 10.1097/00001756-200212030-00038 Ueda, 2002, Enhanced SUMOylation in polyglutamine diseases, Biochem. Biophys. Res. Commun., 293, 307, 10.1016/S0006-291X(02)00211-5 Um, 2006, Functional modulation of parkin through physical interaction with SUMO-1, J. Neurosci. Res., 84, 1543, 10.1002/jnr.21041 Um, 2006, Parkin ubiquitinates and promotes the degradation of RanBP2, J. Biol. Chem., 281, 3595, 10.1074/jbc.M504994200 van Niekerk, 2007, Sumoylation in axons triggers retrograde transport of the RNA-binding protein La, Proc. Natl. Acad. Sci. USA., 104, 12913, 10.1073/pnas.0611562104 Vassilatis, 2003, The G protein-coupled receptor repertoires of human and mouse, Proc. Natl. Acad. Sci. USA, 100, 4903, 10.1073/pnas.0230374100 Wasiak, 2007, Bax/Bak promote sumoylation of DRP1 and its stable association with mitochondria during apoptotic cell death, J. Cell Biol., 177, 439, 10.1083/jcb.200610042 Watanabe, 2008, Developmental regulation of Ubc9 in the rat nervous system, Acta Biochim. Pol., 55, 681, 10.18388/abp.2008_3027 Watts, 2004, SUMO modification of proteins other than transcription factors, Semin. Cell Dev. Biol., 15, 211, 10.1016/j.semcdb.2003.12.002 Wilkinson, 2008, Analysis of SUMO-1 modification of neuronal proteins containing consensus SUMOylation motifs, Neurosci. Lett., 436, 239, 10.1016/j.neulet.2008.03.029 Wolin, 2002, The La protein, Annu. Rev. Biochem., 71, 375, 10.1146/annurev.biochem.71.090501.150003 Yang, 2006, An extended consensus motif enhances the specificity of substrate modification by SUMO, EMBO J., 25, 5083, 10.1038/sj.emboj.7601383 Yang, 2008, Cerebral ischemia/stroke and small ubiquitin-like modifier (SUMO) conjugation–a new target for therapeutic intervention?, J. Neurochem., 106, 989, 10.1111/j.1471-4159.2008.05404.x Yang, 2008, Transient focal cerebral ischemia induces a dramatic activation of small ubiquitin-like modifier conjugation, J. Cereb. Blood Flow Metab., 28, 892, 10.1038/sj.jcbfm.9600601 Yazawa, 1995, Abnormal gene product identified in hereditary dentatorubral-pallidoluysian atrophy (DRPLA) brain, Nat. Genet., 10, 99, 10.1038/ng0595-99 Yeh, 2009, SUMOylation and De-SUMOylation: wrestling with life's processes, J. Biol. Chem., 284, 8223, 10.1074/jbc.R800050200 Zhang, 2008, Sumoylation of amyloid precursor protein negatively regulates Abeta aggregate levels, Biochem. Biophys. Res. Commun., 374, 673, 10.1016/j.bbrc.2008.07.109 Zoghbi, 2000, Glutamine repeats and neurodegeneration, Annu. Rev. Neurosci., 23, 217, 10.1146/annurev.neuro.23.1.217 Zunino, 2009, Translocation of SenP5 from the nucleoli to the mitochondria modulates DRP1-dependent fission during mitosis, J. Biol. Chem., 284, 17783, 10.1074/jbc.M901902200